BlueWillow Biologics Awarded Grant for Chlamydia Vaccine Development

BlueWillow Biologics® today announced the company has been awarded an NIH Small Business Innovation Research (SBIR) grant for the development of an intranasal NanoVax®vaccine for the prevention of chlamydia. There are more than 131 million new chlamydia infections worldwide each year1 and no approved vaccine currently exists to prevent the infection.  The National Institute of … Continued

Blue Medora Secures $10 Million in Growth Investment from Edison Partners

Blue Medora, the IT monitoring integration leader, announced today a $10 million investment from growth equity investor Edison Partners. Proceeds will be used to accelerate development and enterprise market adoption of the company’s innovations including the recently introduced BindPlane™ service. The new investment comes on the heels of a year of dramatic growth for Blue … Continued